Gestational trophoblastic neoplasia: An update

Current Oncology Reports

Volumn 10, Issue 6, 2008, Pages 497-504

  Morgan, Jacqueline M ^a   Lurain, John R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CHLORAMBUCIL; CHORIONIC GONADOTROPIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; IFOSFAMIDE; METHOTREXATE; PACLITAXEL; PLATINUM COMPLEX; VINCRISTINE;

ALOPECIA; ANEMIA; CANCER CLASSIFICATION; CANCER REGRESSION; CANCER RESISTANCE; CANCER STAGING; CENTRAL NERVOUS SYSTEM METASTASIS; CHORIOCARCINOMA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; HIGH RISK PATIENT; HUMAN; HYDATIDIFORM MOLE; HYSTERECTOMY; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PATIENT COMPLIANCE; PROGNOSIS; REVIEW; SALVAGE THERAPY; SCORING SYSTEM; STOMATITIS; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT FAILURE; TROPHOBLASTIC TUMOR;

ANTINEOPLASTIC AGENTS; CHORIONIC GONADOTROPIN; DRUG DESIGN; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; MEDICAL ONCOLOGY; NEOPLASM METASTASIS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; RISK; TROPHOBLASTIC NEOPLASMS;

EID: 58649094611     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-008-0075-y     Document Type: Review

References (51)

1. Lurain JR: Treatment of gestational trophoblastic tumors. Curr Treat Options Oncol 2002, 3: 113-124.
2. Soper JT: Gestational trophoblastic disease. Obstet Gynecol 2006, 108: 176-187.
3. Ngan S, Seckl MJ: Gestational trophoblastiA neoplasia management: an update. Curr Opin Oncol 2007, 19: 486-491.
4. Ngan HYS, Bender H, Benedet JL, et al.: Gestational trophoblastic neoplasia, FIGO staging and classification. Int J Gynecol Obstet 2003, 83: 175-177.
5. Lurain JR: Pharmacotherapy of gestational trophoblastic disease. Expert Opin Pharmacother 2003, 4: 1-13.
6. Kohorn EI: Dynamic staging and risk factor scoring for gestational trophoblastic disease. Int J Gynecol Cancer 2007, 17: 1124-1130.
7. Lurain JR, Elfstrand EP: Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. Am J Obstet Gynecol 1995, 172: 574-579.
8. Berkowitz RS, Goldstein, Bernstein MR: Ten years experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol 1986, 23: 111-118.
9. Bagshawe KD, Dent J, Newlands ES, et al.: The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumors. Br J Obstet Gynecol 1989, 96: 795-802.
10. Wong LC, Choo YC, Ma HK: Methotrexate with citrovorum factor rescue in gestational trophoblastic disease. Am J Obstet Gynecol 1985, 152: 59-62.
11. Berkowitz RS, Goldstein DP, Bernstein MR: Methotrexate infusion with folinic acid in primary therapy of nonmetastatic trophoblastic tumors. Gynecol Oncol 1996, 36: 56-59.
12. Garrett AP, Garner EO, Goldstein DP, Berkowitz RS: Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. J Reprod Med 2002, 47: 355-362.
13. Elit L, Covens A, Osborne R, et al.: High-dose methotrexate for gestational trophoblastic disease. Gynecol Oncol 1994, 54: 282-287.
14. Wong LC, Ngan HYS, Cheng DKL, et al.: Methotrexate infusion in low-risk gestational trophoblastic disease. Am J Obstet Gynecol 2000, 183: 1579-1582.
15. Homesley HD, Blessing JA, Schlaerth J, et al.: Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Obstet Gynecol 1988, 72: 413-418.
16. Hoffman MS, Fiorica JV, Gleeson NC, et al.: A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Gynecol Oncol 1996, 60: 292-294.
17. Petrilli ES, Morrow CP: Actinomycin D toxicity in the treatment of trophoblastic disease. A comparison of the 5-day course to a single-dose administration. Gynecol Oncol 1980, 9: 18-22.
18. Kohorn EI: Decision making for chemotherapy administration in patients with low-risk gestational trophoblastic neoplasia. Int J Gynecol Oncol 1996, 6: 279-285.
19. Abrao RA, deAndrade JM, Tiezzi DG, et al.: Treatment of low-risk gestational trophoblastic disease: Comparison of single-agent methotrexate, dactinomycin and combination regimens. Gynecol Oncol 2008, 108: 149-153.
20. Osborne R, Filiaci V, Schink J, et al.: A randomized phase III trial comparing weekly parenteral methotrexate and "pulsed" dactinomycin as primary management for low-risk gestational trophoblastic neoplasia. A Gynecologic Oncology Group study. Presented at the 39th Annual Meeting of the Society of Gynecologic Oncologists, Tampa, FL, March 9, 2008 [abstract]. Gynecol Oncol 2008, 108: S2.
21. DuBeshter B, Berkowitz RS, Goldtsien DP: Management of low-risk gestational trophoblastic tumors. J Reprod Med 1991, 36: 36-39.
22. Soper JT, Clarke-Pearson DL, Berchuk A, et al.: Five-day methotrexate for women with metastatic gestational trophoblastic disease. Gynecol Oncol 1994, 54: 76-79.
23. Roberts JP, Lurain JR: Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. Am J Obstet Gynecol 1996, 174: 1917-1924.
24. Lurain JR, Brewer JI: Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D and cyclophosphamide chemotherapy. Obstet Gynecol 1985, 65: 830-834.
25. Begent RHJ, Bagshawe KD: The management of high-risk choriocarcinoma. Semin Oncol 1982, 9: 198-203.
26. Curry SL, Blessing JA, DiSaia PJ, et al.: A prospective randomized comparison of methotrexate, actinomycin D and chlorambucil (MAC) versus modified Bagshawe regimen in "poor prognosis" gestational trophoblastic disease. Obstet Gynecol 1989, 73: 357-362.
27. Newlands ES, Bagshawe KD, Begent RJH, et al.: Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high-risk gestational trophoblastic tumors (1979-1989). Br J Obstet Gynecol 1991, 98: 550-557.
28. Bower M, Newlands ES, Holden L, et al.: EMA/CO for high-risk gestational trophoblastic disease. Results from a cohort of 272 patients. J Clin Oncol 1997, 15: 2636-2643.
29. Kim SJ, Bae SN, Kim JH, et al.: Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/ CO regimen. Gynecol Oncol 1998, 71: 247-253.
30. Escobar PF, Lurain JR, Singh DK, et al.: Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy. Gynecol Oncol 2003, 91: 552-557.
31. Turan T, Karacay O, Tulunay G, et al.: Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia. Int J Gynecol Cancer 2006, 16: 1432-1438.
32. Lu WG, Ye F, Shen YM, et al.: EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: A clinical analysis of 54 patients. Int J Gynecol Cancer 2008, 18: 357-362.
33. Lurain JR, Singh DK, Schink JC: Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy. J Reprod Med 2006, 51: 767-772.
34. Soto-Wright V, Goldstein DP, Bernstein MR, et al.: The management of gestational trophoblastic tumors with etoposide, methotrexate and actinomycin D. Gynecol Oncol 1997, 64: 156-159.
35. Matsui H, Suzuka K, Iitsuka Y, et al.: Combination chemotherapy with methotrexate, etoposide and actinomycin D for high-risk gestational trophoblastic tumors. Gynecol Oncol 2000, 78: 28-31.
36. Small W Jr, Lurain JR, Shetty RM, et al.: Gestational trophoblastic disease metastatic to the brain. Radiology 1996, 200: 277-280.
37. Yang J, Xiang Y, Wan X, Yang X: Recurrent gestational trophoblastic tumor: Management and risk factors for recurrence. Gynecol Oncol 2006, 103: 587-590.
38. Ngan HY, Tam KF, Lam KW, Chan KK: Relapsed gestational trophoblastic neoplasia: A 20-year experience. J Reprod Med 2006, 51: 829-834.
39. Powles T, Savage PM, Stebbing J, et al.: A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia. Br J Cancer 2007, 96: 732-737.
40. Mao Y, Wau X, Lv W, Xie X: Relapsed or refractory gestational trophoblastic neoplasia treated with etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen. Int J Gynecol Cancer 2007, 98: 44-47.
41. Lurain JR, Nejad B: Secondary chemotherapy for high-risk gestational trophoblastic neoplasia. Gynecol Oncol 2005, 97: 618-623.
42. Wang J, Short D, Sebire NJ, et al.: Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/ cisplatin alternating with paclitaxel/etoposide (TP/TE). Ann Oncol 2008 May 2 (Epub ahead of print).
43. Lurain JR, Singh DK, Schink JC: Role of surgery in the management of high-risk gestational trophoblastic neoplasia. J Reprod Med 2006, 51: 773-776.
44. Lurain JR, Hoekstra AV, Schink JC: Results of treatment of patients with gestational trophoblastic neoplasia referral to the Brewer Trophoblastic Disease Center after failure of treatment elsewhere (1979-2006). J Reprod Med 2008, (in press).
45. Kohorn E: Regional centers for trophoblastic disease. Am J Obstet Gynecol 2007, 196: 95-96.
46. Hoekstra AV, Lurain JR, Rademaker AW, Schink JC: Gestational trophoblastic neoplasia: Treatment outcomes. Obstet Gynecol 2008, 112: 251-258.
47. Baergen RN, Rutgers JL, Young RH, et al.: Placental site trophoblastic tumor: A study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol 2006, 100: 511-520.
48. Papadopoulos AJ, Foskett M, Seckl MJ, et al.: Twenty-five years' clinical experience with placental site trophoblastic tumors. J Reprod Med 2002, 47: 460-464.
49. Hassadia A, Gillespie A, Tidy J, et al.: Placental site trophoblastic tumor: Clinical features and management. Gynecol Oncol 2005, 99: 603-607.
50. Shih IM, Kurman RJ: EpithelAoid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol 1998, 22: 1393-1403.
51. Cole LA, Butler SA, Khanlian SA, et al.: Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a tumor marker of active neoplasia. Gynecol Oncol 2006, 102: 151-159.